The approval of Revolution Medicines' daraxonrasib for pancreatic cancer is, in the words of Verastem Oncology CEO Dan Paterson, "the biggest ...
The Royal New Zealand Air Force has achieved impressive availability rates with its NH90 fleet, and one of its helicopters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results